Clinorotation-induced autophagy via HDM2-p53-mTOR pathway enhances cell migration in vascular endothelial cells

Cell Death Dis. 2018 Feb 2;9(2):147. doi: 10.1038/s41419-017-0185-2.

Abstract

Individuals exposed to long-term spaceflight often experience cardiovascular dysfunctions characterized by orthostatic intolerance, disability on physical exercise, and even frank syncope. Recent studies have showed that the alterations of cardiovascular system are closely related to the functional changes of endothelial cells. We have shown previously that autophagy can be induced by simulated microgravity in human umbilical vein endothelial cells (HUVECs). However, the mechanism of enhanced autophagy induced by simulated microgravity and its role in the regulation of endothelial function still remain unclear. We report here that 48 h clinorotation promoted cell migration in HUVECs by induction of autophagy. Furthermore, clinorotation enhanced autophagy by the mechanism of human murine double minute 2 (HDM2)-dependent degradation of cytoplasmic p53 at 26S proteasome, which results in the suppression of mechanistic target of rapamycin (mTOR), but not via activation of AMPK in HUVECs. These results support the key role of HDM2-p53 in direct downregulation of mTOR, but not through AMPK in microgravity-induced autophagy in HUVECs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Autophagy* / drug effects
  • Cell Movement* / drug effects
  • Fatty Acids, Unsaturated / pharmacology
  • Gene Knockdown Techniques
  • Human Umbilical Vein Endothelial Cells / cytology*
  • Human Umbilical Vein Endothelial Cells / metabolism*
  • Human Umbilical Vein Endothelial Cells / ultrastructure
  • Humans
  • Leupeptins / pharmacology
  • Models, Biological
  • Phosphorylation / drug effects
  • Proteasome Endopeptidase Complex / metabolism
  • Proteolysis / drug effects
  • Proto-Oncogene Proteins c-mdm2 / metabolism*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rotation*
  • Signal Transduction
  • TOR Serine-Threonine Kinases / metabolism*
  • Time Factors
  • Tumor Suppressor Protein p53 / metabolism*
  • Weightlessness Simulation

Substances

  • Fatty Acids, Unsaturated
  • Leupeptins
  • RNA, Messenger
  • Tumor Suppressor Protein p53
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • AMP-Activated Protein Kinases
  • Proteasome Endopeptidase Complex
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde
  • leptomycin B